Surgical Considerations for Pediatric Snake Bites in Low- and Middle-Income Countries

World J Surg. 2019 Jul;43(7):1636-1643. doi: 10.1007/s00268-019-04953-9.

Abstract

Background: Snake envenomation is associated with major morbidity especially in low- and middle-income countries and may require fasciotomy. We determined patient factors associated with the need for fasciotomy after venomous snake bites in children located in KwaZulu-Natal, South Africa.

Methods: Single institutional review of historical data (2012-2017) for children (<18 years) sustaining snake envenomation was performed. Clinical data, management, and outcomes were abstracted. Syndromes after snake bite were classified according to Blaylock nomenclature: progressive painful swelling (PPS), progressive weakness (PW), or bleeding (B), as it is difficult to reliably identify the species of snake after a bite. Comparative and multivariable analyses to determine factors associated with fasciotomy were performed.

Results: There were 72 children; mean age was 7 (±3) years, 59% male. Feet were most commonly affected (n = 27, 38%) followed by legs (n = 18, 25%). Syndromes (according to Blaylock) included PPS (n = 63, 88%), PW (n = 5, 7%), and B (n = 4, 5%). Eighteen patients underwent fasciotomy, and one required above knee amputation. Nine patients received anti-venom. Few patients (15%) received prophylactic beta-lactam antibiotics. Hemoglobin < 11 mg/dL, leukocytosis, INR >1.2, and age-adjusted shock index were associated with fasciotomy. On regression, age-adjusted shock index and hemoglobin concentration < 11 mg/dL, presentation >24 h after snake bite, and INR >1.2 were independently associated with fasciotomy. Model sensitivity was 0.89 and demonstrated good fit.

Conclusions: Patient factors were associated with the fasciotomy. These factors, coupled with clinical examination, may identify those who need early operative intervention. Improving time to treatment and the appropriate administration of anti-venom will minimize the need for surgery.

Level of evidence: III.

MeSH terms

  • Antivenins / therapeutic use
  • Child
  • Child, Preschool
  • Developing Countries*
  • Edema / etiology*
  • Fasciotomy*
  • Female
  • Hemoglobins / metabolism
  • Humans
  • International Normalized Ratio
  • Leukocytosis / etiology
  • Male
  • Muscle Weakness / etiology
  • Pain / etiology
  • Patient Selection
  • Risk Factors
  • Snake Bites / blood
  • Snake Bites / complications
  • Snake Bites / surgery*
  • South Africa
  • Time-to-Treatment

Substances

  • Antivenins
  • Hemoglobins